Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Uterine carcinosarcoma, drawn from the whole corpus: 6 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
No dedicated randomised trials for a tumour that behaves worse than the serous cancers it is grouped with.
Whether the sarcomatous component needs different drugs.
High relapse rate after apparently complete treatment of stage I disease.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 9 changes by month →When this page itself was last checked or edited.
Endometrial ORR 57.
OS 44.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
5-year OS 81.